Effects of Code Sepsis Implementation on Emergency Department (ED) Sepsis Care

Intermountain Health Care, Inc.3 sites in 1 country180,402 target enrollmentNovember 13, 2018

ConditionsSepsis

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Sepsis
Sponsor: Intermountain Health Care, Inc.
Enrollment: 180402
Locations: 3
Primary Endpoint: Door-to-antibiotic Time
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

Sepsis is a life-threatening complication of infection that can be difficult to recognize and treat promptly. Timely administration of antibiotics for emergency department (ED) patients with sepsis is challenging. The goal of this study is to determine the potential effectiveness and unintended consequences of reorganizing ED care for patients with suspected sepsis.

Registry

clinicaltrials.gov

Start Date

November 13, 2018

End Date

December 28, 2023

Last Updated

2 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Intermountain Health Care, Inc.

Responsible Party

Principal Investigator

Ithan Peltan

Clinical Investigator

Intermountain Health Care, Inc.

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Outcomes

Primary Outcomes

Door-to-antibiotic Time

Time Frame: Up to 24 hours from ED arrival (an average of 3 hours)

Time from sepsis patients' emergency department arrival to intravenous (or equivalent) antibiotic initiation

Secondary Outcomes

All-cause 1-year Mortality(1 year after ED arrival)
All-cause 30-day Mortality(30 days after ED arrival)
Hospital Length of Stay(From the time of admission to hospital discharge (up to 1 year, average 14 days))
Hospital Charges(From the time of admission to hospital discharge (up to 1 year, average 14 days))
All-cause In-hospital Mortality(From the time of admission to hospital discharge (up to 1 year, average 14 days))